InfuSystem Inks Three-Year Distribution Deal With Smith+Nephew For Its Negative Pressure Wound Therapy System And Supplies
Portfolio Pulse from Benzinga Newsdesk
InfuSystem has signed a three-year distribution deal with Smith+Nephew for its Negative Pressure Wound Therapy system and supplies.
August 06, 2024 | 10:37 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
InfuSystem has entered into a three-year distribution agreement with Smith+Nephew for its Negative Pressure Wound Therapy system and supplies.
The partnership with Smith+Nephew is likely to boost InfuSystem's revenue and market presence in the wound therapy sector, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Smith+Nephew has signed a three-year distribution deal with InfuSystem for its Negative Pressure Wound Therapy system and supplies.
The deal with InfuSystem could enhance Smith+Nephew's product offerings and market reach in the wound therapy segment, potentially benefiting its stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80